ARCHIVES

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

Clinical Cooperative Groups Funding To Decrease 42.5 Mil.

October 11, 1985

DCE Board Approves Study of Breast Cancer On Long Island

June 17, 1994

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

September 17, 2010

In Brief: Ames, Rowley, Win National Science Medals; New Building Planned for Pittsburgh Center

January 8, 1999

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

June 23, 2006

Robert Weinburger, Ernst Wynder Win Top Milken Awards

November 2, 1990